HIGHLIGHTS
- who: Dicranostigma franchetianum and collaborators from the Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Heyrovskeho , have published the Article: Antimycobacterial Agents, in the Journal: Biomolecules 2022, 12, x FOR PEER REVIEW of /2022/
- what: As a part of the ongoing research on IAs and their semisynthetic derivatives as potential drugs, this work reports on the isolation of alkaloids from the whole plant of D. franchetianum, preparation of berberine derivatives, and their in_vitro antimycobacterial activity against Mtb H37Ra, and four other mycobacterial strains (M. aurum, M. avium, M. kansasii, and M. smegmatis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.